2022, Vol. 5, Issue 4, Part A

Aim: To evaluate the analgesic efficacy of Epidural ropivacaine 0.2% in postoperative pain relief.

Method: A routine data based observational study involved 50 patients of ASA1, ASA2 who received Epidural 0.2% Ropivacaine and 50 patients who received Epidural 0.125% bupivacaine postoperatively. All patients were monitored for postoperative pain by the visual analogy scale (VAS), requirement of rescue analgesia, hemodynamic parameters and adverse effects.

Results: Postoperative Pain scores, Incidence of hypotension and delayed motor block were comparable between the observational groups.

Conclusion: Ropivacaine 0.2% and bupivacaine 0.125% were equally efficient in rescue analgesic requirement, but ropivacaine had a better safety profile in terms of less hypotension and lesser motor block.